42762-46-9

Usage

Uses

Used in Flavor and Fragrance Industry:
Cinnamaldehyde is used as a key flavoring agent in the food and beverage industry, adding a distinctive sweet and spicy taste to various products. Its unique aroma also makes it a popular choice for use in the perfume and cosmetics industry, where it contributes to the creation of captivating fragrances.
Used in Pharmaceutical Applications:
Due to its antimicrobial properties, cinnamaldehyde is being investigated for its potential use in the development of new pharmaceuticals, particularly as a natural alternative to synthetic antimicrobial agents.
Used in Antioxidant Applications:
Cinnamaldehyde's antioxidant capabilities make it a candidate for use in the development of products designed to combat oxidative stress and related health issues.
Used in Anti-Inflammatory Applications:
The anti-inflammatory effects of cinnamaldehyde are being studied for potential applications in the treatment of various inflammatory conditions.
Used in Pesticide and Insect Repellent Development:
Cinnamaldehyde's potential as a natural pesticide and insect repellent is being explored, offering an eco-friendly alternative to conventional chemical-based products in agriculture and household use.

Upstream product

• 21663-35-4 1-phenyl-pent-3-ene-1,2-diol 

Downstream Products

• 837-80-9 1-methyl-3-phenylnaphthalene 
• 1404100-14-6 C₃₁H₃₇NOSi 
• 1404100-16-8 C₃₁H₃₇NOSi 
• 1404100-20-4 C₃₉H₄₃N₃O₅Si 

Relevant academic research and scientific papers

(Z)- and (E)-γ-Silyloxy Allylic Stannanes. Highly Syn Selective Reagents for SE' Additions to Aldehydes

The (E)-γ-silyloxy allylic stannane 2E, available in one step through addition of Bu(Bu3Sn)Cu(CN)Li2 to crotonaldehyde and subsequent in situ quenching of the enolate with t-BuMe2SiCl, undergoes BF3-promoted addition to representative aldehydes 3a-e, affo

Method for preparing olefine aldehyde through catalytic oxidation of enol ether

The invention relates to the technical field of olefine aldehyde preparation, and provides a method for preparing olefine aldehyde through catalytic oxidation of enol ether. According to the invention, a palladium catalyst, a copper salt, a solvent and enol ether are mixed and subjected to a catalytic oxidation reaction to obtain olefine aldehyde. According to the method, the copper salt is used as the oxidizing agent, the mixed solvent of water and acetonitrile is used as the reaction solvent, and the volume ratio of water to acetonitrile in the mixed solvent is controlled to be (3-7): (3-7), so that the catalytic oxidation reaction can be smoothly carried out in the mixed solvent with a specific ratio, and the generation of palladium black precipitate can be avoided. The method provided by the invention has the advantages of simple steps, low reagent cost, no need of dangerous reagents, wide substrate adaptability and small catalyst dosage. Furthermore, octadecane mercaptan is added to promote the catalytic oxidation reaction, and when the dosage of the palladium catalyst is extremely low, the olefine aldehyde yield can be greatly increased by adding octadecane mercaptan.

Saegusa Oxidation of Enol Ethers at Extremely Low Pd-Catalyst Loadings under Ligand-free and Aqueous Conditions: Insight into the Pd(II)/Cu(II)-Catalyst System

A highly efficient and practical Pd(II)/Cu(OAc)2-catalyst system of Saegusa oxidation, which converts enol ethers to the corresponding enals with a number of diverse substrates at extremely low catalyst loadings (500 mol ppm) under ligand-free and aqueous conditions, is described. Its synthetic utility was demonstrated by large-scale applications of the catalyst system to important nature molecules. This work allows Saegusa oxidation to become a highly practical approach to preparing enals and also suggests new insight into the Pd(II)/Cu(II)-catalyst system for dehydrogenation of carbonyl compounds and decreasing Pd-catalyst loadings.

1-substituted, 3-carboxylic acid piperidine derivatives

The present invention relates to therapeutically active azaheterocyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating a central nervous system ailment related to the GABA uptake.